ARTEMIS Pharmaceuticals Company Profile

10:47 EDT 19th March 2018 | BioPortfolio

ARTEMIS Pharmaceuticals, based in Cologne Germany was founded in 1998 and has made significant advances to provide rapid, efficient and sophisticated techniques for the analysis of gene function in vertebrates.We are a wholly-owned subsidiary of Exelixis Inc., South San Francisco CA (NASDAQ: EXEL), but operate a distinct business model. Our activities are dedicated towards the provision of transgenic mouse generation services, tools and related licenses to the industrial and academic community. We operate on a fee for service basis and have a wide range of collaboration possibilities to provide solutions for our customers. Customers include Merck and Co. Inc., Bayer AG, Sanofi-Aventis, Biovitrum, EVOTEC Neurosciences, Regeneron Pharmaceuticals, Schering AG, Boehringer Ingelheim and a large number of other companies and universities.


Neurather Ring 1


Phone: 49 (0) 221-964 53-10
Fax: 49 (0) 221-964 53-21

News Articles [500 Associated News Articles listed on BioPortfolio]

FDA orphan status given to Artemis' malaria drug

Artemis Therapeutics' Artemisone, which is being developed as a treatment for patients with P.  -More- 

Artemis receives Orphan designation for Malaria treatment artemisone

Artemis Therapeutics, a pharmaceutical company developing new therapies for the treatment of life-threatening infectious diseases, announced that the FDA granted orphan drug designation for Artemisone...

Eureka to start phase I ET190L1-ARTEMIS T cell therapy trial

Eureka Therapeutics, a clinical stage biotechnology company focused on improving the safety profile of T cell therapies and developing novel T cell therapies for the treatment of solid tumors, announc...

Eureka Therapeutics Closes $60 Million in Series D Financing to Advance Proprietary ARTEMIS™ T Cell Receptor Platform for Safer T Cell Therapies

Eureka Therapeutics, Inc., a clinical stage biotechnology company focused on improving the safety profile of T cell therapies and developing novel T cell therapies for the treatme...

Eureka Announces FDA Allowance of Investigational New Drug Application for ET190L1-ARTEMIS™ T cell Therapy in Relapsed and Refractory CD19+ Non-Hodgkin Lymphoma

Eureka Therapeutics, Inc., a clinical stage biotechnology company focused on improving the safety profile of T cell therapies and developing novel T cell therapies for the treatme...

Salix Pharmaceuticals (SLXP) vs. Its Rivals Head to Head Survey

Salix Pharmaceuticals is one of 19 public companies in the "Specialty & Advanced Pharmaceuticals" industry, but how does it contrast to its rivals? We will compare Salix Pharmaceuticals to related...

Eureka Therapeutics closes $60mm Series D round

Eureka Therapeutics Inc. (developing T-cell immunotherapies for solid tumors) raised $60mm in its Series D round led by Acorn Pacific Ventures. GP Capital and all existing investors also participated....

Critical Contrast: Ironwood Pharmaceuticals

Ironwood Pharmaceuticals and Infinity Pharmaceuticals are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, risk, d...

Drugs and Medications [272 Associated Drugs and Medications listed on BioPortfolio]

Artemis alcohol-free antiseptic foam hand [Artemis Bio-Solutions Inc]

ARTEMIS ALCOHOL-FREE Antiseptic Foam Hand Soap

Artemis alcohol-free antiseptic foam hand sanitizer [Artemis Bio-Solutions Inc]

ARTEMIS ALCOHOL-FREE Antiseptic Foam Hand Sanitizer

Pur-wash [Niagara Pharmaceuticals Inc.]


Bacitracin [Qualitest Pharmaceuticals]

Bacitracin Ointment, USP

Pur-wash [Niagara Pharmaceuticals Inc.]

Pur-Wash Purified Water, 98.3% Ophthalmic Solution Eyewash

PubMed Articles [121 Associated PubMed Articles listed on BioPortfolio]

Suspended solids moderate the degradation and sorption of waste water-derived pharmaceuticals in estuarine waters.

This study focuses on the fate of pharmaceuticals discharged into an estuarine environment, particularly into the Turbidity Maximum Zone (TMZ). Batch experiments were set up to investigate the factors...

Chiral pharmaceuticals: A review on their environmental occurrence and fate processes.

More than 50% of pharmaceuticals in current use are chiral compounds. Enantiomers of the same pharmaceutical have identical physicochemical properties, but may exhibit differences in pharmacokinetics,...

Genetics of familial hypercholesterolemia: a tool for development of novel lipid lowering pharmaceuticals?

Familial hypercholesterolemia is characterized by high LDL cholesterol and an elevated risk to develop coronary heart disease. Mutations in LDL receptor-mediated cholesterol uptake are the main cause ...

A General Strategy for Site-Selective Incorporation of Deuterium and Tritium into Pyridines, Diazines and Pharmaceuticals.

Methods to incorporate deuterium and tritium atoms into organic molecules are valuable for medicinal chemistry. The prevalence of pyridines and diazines in pharmaceuticals means that new ways to label...

Effects of exposure to pharmaceuticals (diclofenac and carbamazepine) spiked sediments in the midge, Chironomus riparius (Diptera, Chironomidae).

Human and veterinary pharmaceuticals and degradation products are continuously introduced into the environment. To date, there is a lack of information about the effects of pharmaceuticals in spiked t...

Clinical Trials [223 Associated Clinical Trials listed on BioPortfolio]

Clinical Study of ET190L1-ARTEMIS™ in Relapsed, Refractory B Cell Lymphoma

This study is to determine the safety, including potential dose limiting toxicities, of ET190L1-ARTEMIS™ T cells and the duration of in vivo survival of ET190L1-ARTEMIS™ T cells in pat...

MIND: Artemis in the Removal of Intracerebral Hemorrhage

The primary objective of this multicenter randomized controlled study is to compare the safety and efficacy of minimally invasive hematoma evacuation with the Artemis Neuro Evacuation Devi...

Study of ET190L1-ARTEMIS™ T Cells in Relapsed and Refractory CD19+ Non-Hodgkin's Lymphoma

This is a non-randomized, single arm, open-label, single institution, phase I study to determine the maximum tolerated dose (MTD) of ET190L1-ARTEMIS™ T cells in patients ≥ 18 years of ...

Measurements of Myocardial Relaxation Time by MRI During Respiration

Measurement of T2 transversal relaxation time by magnetic resonance has a major interest in cardiac imagery. It has been initially used for quantitative evaluation of heart viability and m...

(ARTEMIS-IPF)Randomized, Placebo-Controlled Study to Evaluate Safety and Effectiveness of Ambrisentan in IPF

The ARTEMIS-IPF study is for people who have been diagnosed with IPF and are between 40-80 years of age. People who have been diagnosed early in the disease may be more responsive to treat...

Companies [1312 Associated Companies listed on BioPortfolio]

Artemis Health Group

Artemis is the nation’s leading provider of specialty-specific electronic medical record (EMR), workflow and mobile patient engagement solutions to help bridge the gap betwee...

ARTEMIS Pharmaceuticals

ARTEMIS Pharmaceuticals, based in Cologne Germany was founded in 1998 and has made significant advances to provide rapid, efficient and sophisticated techniques for the analysis of gene function in ve...

Artemis International, Inc.

ARTEMISPharmaceuticals GmbH

ARTEMIS has developed the ArteMice™ platform, a combination of rapid and sophisticated gene vector design, efficient and expert ES cell transfection techniques, novel blastocyst injection techniques...

Artemis Search

We have been recruiting in the biotechnology arena since 1987. We offer COntract recruitment, executive search and research services exclusiviely to the biotech industry.

More Information about "ARTEMIS Pharmaceuticals" on BioPortfolio

We have published hundreds of ARTEMIS Pharmaceuticals news stories on BioPortfolio along with dozens of ARTEMIS Pharmaceuticals Clinical Trials and PubMed Articles about ARTEMIS Pharmaceuticals for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ARTEMIS Pharmaceuticals Companies in our database. You can also find out about relevant ARTEMIS Pharmaceuticals Drugs and Medications on this site too.

Quick Search


Relevant Topics

Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Corporate Database Quicklinks

Searches Linking to this Company Record